The clinical outcomes and effectiveness of antiviral agents among underweight patients with COVID-19.

Jheng-Yen WuMei-Yuan LiuMei-Chuan LeeKuo-Chuan HungWan-Hsuan HsuYa-Wen TsaiTing-Hui LiuPo-Yu HuangMin-Hsiang ChuangShu-Ching TsengChih-Ying LuChih-Cheng Lai

Published in: Expert review of anti-infective therapy (2024)

Underweight status may be associated with a higher risk of all-cause hospitalization and death in patients with COVID-19.Among underweight patients, antiviral agents demonstrated clinically beneficial effects.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
randomized controlled trial
systematic review
patient reported outcomes
patient reported